All News | Pharmya

2023 March Mar 30

Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM

2023 March Mar 27

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

2023 March Mar 23

WHO Pharmaceuticals Newsletter

2023 March Mar 20

Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes

2023 March Mar 17

Guideline on computerised systems and electronic data in clinical trials

2023 March Mar 13

EU-PRAC recommendations on signals adopted at the 6-9 February 2023 meeting

2023 March Mar 09

Welcome to the team!

The Pharmya team is growing! A big welcome to Angélique, our new team assistant!

2023 March Mar 06

Letter to QPPVs – International Transfer of ICSRs from EV and GDPR

2023 March Mar 03

Questions and answers – Clinical Trials Information System (CTIS) and Clinical Trials Regulation (CTR)

2023 February Feb 27

List of medicines under additional monitoring

https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring

« Previous